These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36328419)

  • 1. An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.
    Kruger DJ; Glynos NG; Fields CW; Herberholz M; Boehnke KF
    J Psychoactive Drugs; 2023; 55(4):420-424. PubMed ID: 36328419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers.
    Boehnke KF; Cox K; Weston C; Herberholz M; Glynos N; Kolbman N; Fields CW; Barron J; Kruger DJ
    Front Psychiatry; 2023; 14():1224551. PubMed ID: 37599880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
    Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M
    BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.
    Kruger DJ; Enghoff O; Herberholz M; Barron J; Boehnke KF
    J Psychoactive Drugs; 2023; 55(5):631-639. PubMed ID: 37078418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.
    VanderZwaag B; Garcia-Romeu A; Garcia-Barrera MA
    Ther Adv Psychopharmacol; 2024; 14():20451253241264812. PubMed ID: 39132012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.
    Wilkes R; Roberts DM; Liknaitzky P; Brett J
    Clin Toxicol (Phila); 2024 Apr; 62(4):242-247. PubMed ID: 38753585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
    Rosenbaum D; Weissman C; Anderson T; Petranker R; Dinh-Williams LA; Hui K; Hapke E
    J Psychopharmacol; 2020 Jun; 34(6):612-622. PubMed ID: 32108529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of classic psychedelics among adults: a Danish online survey study.
    Søgaard Juul T; Ebbesen Jensen M; Fink-Jensen A
    Nord J Psychiatry; 2023 May; 77(4):367-378. PubMed ID: 36173202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
    Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cessation and reduction in alcohol consumption and misuse after psychedelic use.
    Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW
    J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturalistic Psychedelic Use: A World Apart from Clinical Care.
    Glynos NG; Fields CW; Barron J; Herberholz M; Kruger DJ; Boehnke KF
    J Psychoactive Drugs; 2023; 55(4):379-388. PubMed ID: 35950817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.
    Nadeem Z; Parker S; McGovern H; Oestreich LK
    Aust N Z J Psychiatry; 2024 Oct; 58(10):904-913. PubMed ID: 38907608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
    Kucsera A; Suppes T; Haug NA
    Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics.
    Kruger DJ; Barron J; Herberholz M; Boehnke KF
    J Psychoactive Drugs; 2023; 55(5):650-659. PubMed ID: 37353935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State Cannabis and Psychedelic Legislation and Microdosing Interest in the US.
    Yang KH; Satybaldiyeva N; Allen MR; Ayers JW; Leas EC
    JAMA Health Forum; 2024 Jun; 5(6):e241653. PubMed ID: 38941086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.
    Hutten NRPW; Mason NL; Dolder PC; Kuypers KPC
    Front Psychiatry; 2019; 10():672. PubMed ID: 31572246
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.
    Vamvakopoulou IA; Nutt DJ
    Eur Addict Res; 2024; 30(5):302-320. PubMed ID: 39321788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical student attitudes and perceptions of psychedelic-assisted therapies.
    Li I; Fong R; Hagen M; Tabaac B
    Front Psychiatry; 2023; 14():1190507. PubMed ID: 37441143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.